Targeted therapies: Cetuximab dosing by rash--is the scaling of EVEREST meaningful?

Nat Rev Clin Oncol. 2012 Oct;9(10):554-6. doi: 10.1038/nrclinonc.2012.142. Epub 2012 Aug 14.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / administration & dosage*
  • Cetuximab
  • Dose-Response Relationship, Drug
  • Drug Eruptions / etiology*
  • Humans
  • Neoplasms / drug therapy*
  • Skin Diseases / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Cetuximab